Global enzyme poly adp ribose polymerase inhibitor Trends: Region-Specific Insights 2026-2034
Explore the dynamic PARP inhibitor market, valued at $8.8 billion in 2025, and its projected 10.7% CAGR. Discover key drivers, trends, restraints, applications, and leading companies shaping the future of cancer therapy.
